OPKO Health Long Term Debt 2010-2023 | OPK
OPKO Health long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
| OPKO Health Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $214 |
| 2022 | $210 |
| 2021 | $188 |
| 2020 | $222 |
| 2019 | $211 |
| 2018 | $57 |
| 2017 | $29 |
| 2016 | $44 |
| 2015 | $49 |
| 2014 | $131 |
| 2013 | $212 |
| 2012 | $ |
| 2011 | $25 |
| 2010 | $ |
| 2009 | $15 |
| OPKO Health Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2023-12-31 | $214 |
| 2023-09-30 | $213 |
| 2023-06-30 | $212 |
| 2023-03-31 | $211 |
| 2022-12-31 | $210 |
| 2022-09-30 | $142 |
| 2022-06-30 | $211 |
| 2022-03-31 | $211 |
| 2021-12-31 | $188 |
| 2021-09-30 | $186 |
| 2021-06-30 | $183 |
| 2021-03-31 | $225 |
| 2020-12-31 | $222 |
| 2020-09-30 | $219 |
| 2020-06-30 | $216 |
| 2020-03-31 | $214 |
| 2019-12-31 | $211 |
| 2019-09-30 | $209 |
| 2019-06-30 | $206 |
| 2019-03-31 | $204 |
| 2018-12-31 | $57 |
| 2018-09-30 | $57 |
| 2018-06-30 | $56 |
| 2018-03-31 | $55 |
| 2017-12-31 | $29 |
| 2017-09-30 | $29 |
| 2017-06-30 | $35 |
| 2017-03-31 | $39 |
| 2016-12-31 | $44 |
| 2016-09-30 | $52 |
| 2016-06-30 | $45 |
| 2016-03-31 | $50 |
| 2015-12-31 | $49 |
| 2015-09-30 | $44 |
| 2015-06-30 | $109 |
| 2015-03-31 | $107 |
| 2014-12-31 | $131 |
| 2014-09-30 | $115 |
| 2014-06-30 | $116 |
| 2014-03-31 | $225 |
| 2013-12-31 | $212 |
| 2013-09-30 | $209 |
| 2013-06-30 | $189 |
| 2013-03-31 | $276 |
| 2012-12-31 | |
| 2012-09-30 | $33 |
| 2012-06-30 | $23 |
| 2012-03-31 | $22 |
| 2011-12-31 | $25 |
| 2011-09-30 | $2 |
| 2011-06-30 | $2 |
| 2011-03-31 | $2 |
| 2010-12-31 | |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-12-31 | $15 |
| 2009-09-30 | $15 |
| 2009-06-30 | $14 |
| 2009-03-31 | $14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.850B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.088B | 26.31 |
| Intuitive Surgical (ISRG) | United States | $131.461B | 79.19 |
| Edwards Lifesciences (EW) | United States | $51.022B | 33.20 |
| DexCom (DXCM) | United States | $50.661B | 76.74 |
| IQVIA Holdings (IQV) | United States | $42.066B | 24.95 |
| IDEXX Laboratories (IDXX) | United States | $40.926B | 48.93 |
| Alcon (ALC) | Switzerland | $38.255B | 28.21 |
| STERIS (STE) | Ireland | $20.213B | 23.92 |
| Waters (WAT) | United States | $18.329B | 26.30 |
| Hologic (HOLX) | United States | $17.786B | 19.63 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.523B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.385B | 85.32 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.347B | 15.25 |
| Sysmex ADR (SSMXY) | Japan | $10.045B | 31.50 |
| Teleflex (TFX) | United States | $9.832B | 15.44 |
| Penumbra (PEN) | United States | $7.615B | 94.00 |
| Masimo (MASI) | United States | $7.112B | 39.88 |
| Globus Medical (GMED) | United States | $6.740B | 21.37 |
| Glaukos (GKOS) | United States | $4.818B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.740B | 22.60 |
| TransMedics (TMDX) | United States | $3.079B | 294.16 |
| LivaNova (LIVN) | United Kingdom | $3.019B | 19.84 |
| Elekta AB (EKTAY) | Sweden | $2.766B | 18.97 |
| PROCEPT BioRobotics (PRCT) | United States | $2.723B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.442B | 20.65 |
| Tandem Diabetes Care (TNDM) | United States | $2.369B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.293B | 9.41 |
| Inari Medical (NARI) | United States | $2.164B | 0.00 |
| RxSight (RXST) | United States | $1.938B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.764B | 0.00 |
| Veracyte (VCYT) | United States | $1.496B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.835B | 15.45 |
| Artivion (AORT) | United States | $0.808B | 93.43 |
| Silk Road Medical (SILK) | United States | $0.767B | 0.00 |
| Paragon 28 (FNA) | United States | $0.764B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.705B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.640B | 0.00 |
| SiBone (SIBN) | United States | $0.588B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.572B | 19.43 |
| IRadimed (IRMD) | United States | $0.514B | 29.86 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.486B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.407B | 0.00 |
| Nevro (NVRO) | United States | $0.388B | 0.00 |
| NeuroPace (NPCE) | United States | $0.373B | 0.00 |
| CVRx (CVRX) | United States | $0.335B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.327B | 11.02 |
| AxoGen (AXGN) | United States | $0.280B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.275B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.261B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
| Accuray (ARAY) | United States | $0.211B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| 908 Devices (MASS) | United States | $0.188B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.180B | 9.67 |
| Alpha Tau Medical (DRTS) | Israel | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.160B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.147B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.144B | 0.00 |
| Neuronetics (STIM) | United States | $0.101B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.099B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Envoy Medical (COCH) | United States | $0.083B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.065B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 125.33 |
| SEP Acquisition (SEPA) | United States | $0.061B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.061B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Vasomedical (VASO) | United States | $0.052B | 9.42 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| InspireMD (NSPR) | Israel | $0.045B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| DarioHealth (DRIO) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.019B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.019B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.018B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |